http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012912-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d3ed5f7ce781d5b771bbb2d032202d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d50e3f7ff2e0b0472732ed6f719e87d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220cac89fd6434bef0ad1549a2a9bcec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e44b64dabd9985ef6b2d84ff473b265
publicationDate 2010-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010012912-A2
titleOfInvention Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation
abstract The invention relates to a novel use of the soluble forms of HLA-G in the treatment or prophylaxis of abnormal B-cell proliferation, such as liquid cancers of the B type.
priorityDate 2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2828403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005002617-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2810047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007131575-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4936

Total number of triples: 53.